期刊文献+

^(153)Gd—DTPA的合成及其在小鼠体内分布的实验研究 被引量:2

Synthesis and biodistribution of  ̄(153)Gd-DTPA in mice
下载PDF
导出
摘要 利用放射性元素153Gd合成153Gd-DTPA,经小鼠尾静脉注射后,取5、15、30、60、120、180min六个时相处死小鼠,解剖,测量各脏器放射性计数,计算得到不同时相153Gd-DTPA在各脏器的分布情况。血药清除符合二室模型,t1/2(1)=1.5min、t1/2(2)=29.9min,尿液中药物排泄量t1/2=16min,3h时药物90%量在膀胱中。该药物主要通过肾脏代谢,其余脏器摄取甚少。通过153Gd-DTPA动物实验研究得到了Gd-DTPA的药代动力学数据。 Gd-DTPA was synthesized by 153GdCl3 and DTPA.The mice killed and biodistribution of the organs measured at 5,15,30,60,120 and 180 min post-injection. Blood 153Gd-DTPA clearence curve conformed a two-compartment open model,t1/2(1)= 1.smin,t1/2(2)= 29.gmin. Determination of urine 153Gd-DTPA concentration find: t1/2=16min.Within three hours,90 percent of the drug was concentrated in urine, thereby mainly excreated through kidney.
出处 《核技术》 CAS CSCD 北大核心 1995年第5期278-281,共4页 Nuclear Techniques
关键词 钇153 小鼠 DTPA 药代动力学 核磁共振成像 Contrast-enhancing agent,Gadolinium-diethylenetriamine pentaacetic acid,153Gd,Pharmacokinetic
  • 相关文献

参考文献1

共引文献1

同被引文献19

  • 1Prato FS, Wisenberg G, Marshall TP, et al. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats[J]. J Nucl Med, 1988, 29(10):1 683-1 687.
  • 2Russell CD, Bischoff PG, Rowell KL, et at. Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication[J]. J Nucl Med, 1983, 24(8): 722-727.
  • 3Russell CD, Rowell K, Scott JW. Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man [J]. J Nucl Med, 1986, 27(4): 560-562.
  • 4Rootweh K, Falch D, Sjokvist R. Determination of glomerular filtration rate (GFR) by analysis of capillary blood after single shot injection of ^99mTcDTPA[J]. Eur J Nucl Med, 1980, 5(2): 97-102.
  • 5Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with ^99mTc-DTPA autoradiography in rats[J]. Radiology, 1999, 211(3): 698-708.
  • 6Weinmann H J, Brasch RC, Press WR, et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent [J]. Am J Roentgenol, 1984, 142(3): 619-624.
  • 7Agha N, Persson RB. Comparative labelling and biokinetic studies of ^99mTc-EDTA (Sn) and ^99mTc- DTPA(Sn) [J]. Nuklearmedizin, 1977, 16 (1): 30-35.
  • 8Boutry S, Burtea C, Laurent S, et al. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent[J]. Magn Reson Med, 2005, 53(4): 800-807.
  • 9Feng Y, Zong Y, Ke T, et al. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model[J].Pharm Res, 2006, 23(8): 1 736-1 742.
  • 10Mohs AM, Nguyen T, Jeong EK. et al. Modification of Gd-DTPA cystine copolymers with PEG- 1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography[J]. Magn Reson Med, 2007, 58(1): 110-118.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部